| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |